Effect of grape seed proanthocyanidins on tumor vasculogenic mimicry in human triple-negative breast cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 2, 2015, Pages 531-535

  Luan, Yun Yan ^a   Liu, Zi Min ^a   Zhong, Jin Yi ^b   Yao, Ru Yong ^a   Yu, Hong Sheng ^a  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Grape seed proanthocyanidins; Human triple negative breast cancer cells; Vasculogenic mimicry

Indexed keywords

GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDINS; NUCLEAR PROTEIN; PROANTHOCYANIDIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; PATHOLOGY; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL CULTURE; VITIS; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GRAPE SEED EXTRACT; HUMANS; NUCLEAR PROTEINS; PROANTHOCYANIDINS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR; VITIS;

EID: 84925452727     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.2.531     Document Type: Article

References (32)

1. Basu GD, Liang WS, Stephan DA, et al (2006). A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res, 8, 69.
2. Bergers G, Hanahan D (2008). Modes of resistance to antiangiogenic therapy. Nat Rev Cancer, 8, 592-603.
3. Chen Y, Jing Z, Luo C, et al (2012). Vasculogenic mimicrypotential target for glioblastoma therapy: an in vitro and in vivo study. Med Oncol, 29, 324-31.
4. Di Cosimo S, Baselga J (2010). Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]. Nat Rev Clin Oncol, 7, 139-47.
5. Feng L-L, Liu B-X, Zhong J-Y, et al (2014). Effect of grape procyanidins on tumor angiogenesis in liver cancer xenograft models. Asian Pac J Cancer Prev, 15, 737-41.
6. Han J, Bae SY, Oh SJ, et al (2014). Zerumbone suppresses IL-1beta-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells. Phytother Res.
7. Hendrix MJ, Seftor EA, Hess AR, et al (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer, 3, 411-21.
8. Huang S, Yang N, Liu Y, et al (2012). Grape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1. Int J Mol Med, 30, 1410-6.
9. Lee CH, Wu YT, Hsieh HC, et al (2014). Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells. Biochimie, 104, 117-26.
10. Liu TJ, Sun BC, Zhao XL, et al (2013). CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Oncogene, 32, 544-53.
11. Lu XS, Sun W, Ge CY, et al (2013). Contribution of the PI3K/ MMPs/Ln-5gamma2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol, 42, 2103-15.
12. Ma JL, Han SX, Zhu Q, et al (2011). Role of Twist in vasculogenic mimicry formation in hypoxic hepatocellular carcinoma cells in vitro. Biochem Biophys Res Commun, 408, 686-91.
13. Maniotis AJ, Folberg R, Hess A, et al (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 155, 739-52.
14. Mantena SK, Baliga MS, Katiyar SK (2006). Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis, 27, 1682-91.
15. Meeran SM, Vaid M, Punathil T, et al (2009). Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7, 12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis, 30, 520-8.
16. Nandakumar V, Singh T, Katiyar SK (2008). Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett, 269, 378-87.
17. Redig AJ, McAllister SS (2013). Breast cancer as a systemic disease: a view of metastasis. J Intern Med, 274, 113-26.
18. Rhodes LV, Tate CR, Segar HC, et al (2014). Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Res Treat, 145, 593-604.
19. Seftor RE, Hess AR, Seftor EA, et al (2012). Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol, 181, 1115-25.
20. Soda Y, Myskiw C, Rommel A, et al (2013). Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med, 91, 439-48.
21. Sun Q, Prasad R, Rosenthal E, et al (2011a). Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition. BMC Complement Altern Med, 11, 134.
22. Sun T, Sun BC, Zhao XL, et al (2011b). Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology, 54, 1690-706.
23. Sun T, Zhao N, Zhao XL, et al (2010). Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatol, 51, 545-56.
24. Takano S (2012). Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation. Brain Tumor Pathol, 29, 73-86.
25. Taylor MA, Davuluri G, Parvani JG, et al (2013). Upregulated WAVE3 expression is essential for TGF-beta-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat, 142, 341-53.
26. van der Schaft DW, Seftor RE, Seftor EA, et al (2004). Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst, 96, 1473-7.
27. Xu Y, Li Q, Li XY, et al (2012). Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis. J Exp Clin Cancer Res, 31, 16.
28. Yang J, Mani SA, Donaher JL, et al (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-39.
29. Yoshida T, Ozawa Y, Kimura T, et al (2014). Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer, 110, 1497-505.
30. Yue L, Wang Y, Wang H, et al (2012). Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Oncol Rep, 28, 1453-60.
31. Zhang JT, Sun W, Zhang WZ, et al (2014). Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/ Ln-5gamma2 signaling pathway. BMC Cancer, 14, 193.
32. Zhao XL, Sun T, Che N, et al (2011). Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med, 15, 691-700.